{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"submitter":["Degenhardt L"],"funding":["World Health Organization","NIDA NIH HHS","FIC NIH HHS","NIMH NIH HHS","National Health and Medical Research Council","Lundbeck Foundation"],"pagination":["534-552"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC7059958"],"repository":["biostudies-literature"],"omics_type":["Unknown"],"volume":["114(3)"],"pubmed_abstract":["<h4>Background and aims</h4>The World Health Organization's (WHO's) proposed International Classification of Diseases, 11th edition (ICD-11) includes several major revisions to substance use disorder (SUD) diagnoses. It is essential to ensure the consistency of within-subject diagnostic findings throughout countries, languages and cultures. To date, agreement analyses between different SUD diagnostic systems have largely been based in high-income countries and clinical samples rather than general population samples. We aimed to evaluate the prevalence of, and concordance between diagnoses using the ICD-11, The WHO's ICD 10th edition (ICD-10) and the Diagnostic and Statistical Manual of Mental Disorders, 4th and 5th editions (DSM-IV, DSM-5); the prevalence of disaggregated ICD-10 and ICD-11"],"journal":["Addiction (Abingdon, England)"],"pubmed_title":["Concordance between the diagnostic guidelines for alcohol and cannabis use disorders in the draft ICD-11 and other classification systems: analysis of data from the WHO's World Mental Health Surveys."],"pmcid":["PMC7059958"],"funding_grant_id":["001","R01 DA016558","R01 DA044170","R01 MH070884","U01 MH060220","R13 MH066849","R01 MH069864","R03 TW006481","1081984","R248-2017-2003"],"pubmed_authors":["Lee S","Bunting B","Cia AH","Sasu CC","Navarro-Mateu F","Alonso J","McGrath JJ","Scott K","Chatterji S","Moskalewicz J","Kessler RC","Aguilar-Gaxiola S","Karam EG","Degenhardt L","Lago L","Gureje O","Khalaf M","Bharat C","Mneimneh Z","Caldas-de-Almeida JM","Andrade LH","Poznyak V","Bruno R","Sampson NA","WHO World Mental Health Survey Collaborators","Torres Y","Glantz MD"],"additional_accession":[]},"is_claimable":false,"name":"Concordance between the diagnostic guidelines for alcohol and cannabis use disorders in the draft ICD-11 and other classification systems: analysis of data from the WHO's World Mental Health Surveys.","description":"<h4>Background and aims</h4>The World Health Organization's (WHO's) proposed International Classification of Diseases, 11th edition (ICD-11) includes several major revisions to substance use disorder (SUD) diagnoses. It is essential to ensure the consistency of within-subject diagnostic findings throughout countries, languages and cultures. To date, agreement analyses between different SUD diagnostic systems have largely been based in high-income countries and clinical samples rather than general population samples. We aimed to evaluate the prevalence of, and concordance between diagnoses using the ICD-11, The WHO's ICD 10th edition (ICD-10) and the Diagnostic and Statistical Manual of Mental Disorders, 4th and 5th editions (DSM-IV, DSM-5); the prevalence of disaggregated ICD-10 and ICD-11","dates":{"release":"2019-01-01T00:00:00Z","publication":"2019 Mar","modification":"2025-05-31T22:36:35.245Z","creation":"2020-05-22T12:12:51Z"},"accession":"S-EPMC7059958","cross_references":{"pubmed":["30370636"],"doi":["10.1111/add.14482"]}}